Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetylated Natural Nucleotides for Hand-foot Syndrome
NCT04592731Completed
- Start
- Nov 2020
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of acetylated natural nucleotides in hand-foot syndrome (HFS). Primary endpoint: Proportion of patients who achieve NCI CTCAE v5.0 Palmar-Plantar Erythrodysesthesia Grade 0 or 1 at 6 weeks. Started Nov 2020; status: completed.
02
Drugs
acetylated natural nucleotides
03
Conditions
hand-foot syndrome (HFS)
Beyond the preview
Go deeper on NCT04592731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04592731.